The role of the novel adipocyte-derived hormone adiponectin in human disease

European Journal of Endocrinology

Volumn 148, Issue 3, 2003, Pages 293-300

  Díez, Juan J ^b   Iglesias, Pedro ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CELL ADHESION MOLECULE; COLLAGEN TYPE 10; COLLAGEN TYPE 8; COMPLEMENT COMPONENT C1Q; CYTOKINE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; THIAZOLIDINE DERIVATIVE; TRIACYLGLYCEROL;

ANOREXIA NERVOSA; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BODY MASS; CHRONIC KIDNEY FAILURE; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; MACROPHAGE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SHORT SURVEY; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEINS;

EID: 0037356826     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480293     Document Type: Short Survey

References (72)

1. Trayhurn P & Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society 2001 60 329-339.
2. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Annals of Internal Medicine 1999 130 651-657.
3. Cianflone K, Maslowska M & Sniderman AD. Acylation stimulating protein (ASP), and adipocyte autocrine: new directions. Seminars in Cell Development and Biology 1999 10 31-41.
4. Murray I, Sniderman AD, Havel PJ & Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. Journal of Biological Chemistry 1999 274 36219-36225.
5. Hotamisligil GS, Shargill NS & Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Seience 1993 259 87-91.
6. Auwerx J, Bouillon R, Collen D & Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988 8 68-72.
7. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001 409 307-312.
8. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y & Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications 1996 221 286-289.
9. Nakano Y, Tobe T, Choi-Miura NH, Mazda T & Tomita T. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Journal of Biochemistry 1996 120 803-812.
10. Scherer PE, Williams S, Fogliano M, Baldini G & Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 1995 270 26746-26749.
11. Hu E, Liang P & Spiegelman BM. AdipoQ is a novel adipocyte-specific gene dysregulated in obesity. Journal of Biological Chemistry 1996 271 10697-10703.
12. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M et al. Genomic structure and mutations in adipose-specific gene, adiponectin. International Journal of Obesity 2000 24 861-868.
13. Kishore U & Reid KB. C1q: structure, function, and receptors. Immunopharmacology 2000 49 159-170.
14. Shapiro L & Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology 1998 8 335-338.
15. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J et al. Paradoxical decrease of an adipocyte specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
16. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 2473-2476.
17. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al. Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through cAMP-dependent pathway. Circulation 2000 102 1296-1301.
18. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000 96 1723-1732.
19. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry 2002 277 37487-37491.
20. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J et al. Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 2002 277 25863-25866.
21. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D. Hammond CD et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. International Journal of Reproduction and Diabetes Research 2000 1 51-58.
22. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 2002 8 731-737.
23. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS & Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. PNAS 2001 97 11371-11376.
24. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001 50 1126-1133.
25. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT et al. Proteolitic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. PNAS 2001 98 2005-2010.
26. Berg AH, Combs TP, Du X, Brownlee M & Scherer P. The adipocyte-secreted protein ACRP30 enhances hepatic insulin action. Nature Medicine 2001 7 947-953.
27. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 1288-1295.
28. Wang Y, Xu A, Knight C, Xu LY & Cooper GJ. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. Journal of Biological Chemistry 2002 277 19521-19529.
29. Ma K, Cabrero A, Saha PK, Kojima H, Li L, Chang BH et al. Increased β-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. Journal of Biological Chemistry 2002 277 34658-34661.
30. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 941-946.
31. Rocchi S & Auwerx J. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Annals of Medicine 1999 31 342-351.
32. Picard F & Auwerx J. PPARγ and glucose homeostasis. Annual Review of Nutrition 2002 22 167-197.
33. Lin WS, Chang HM, Tai TY & Chuang LM. Effect of thiazolidinedione on gene expression in NIH3T3-L1 adipocytes. Diabetes 1999 48 (Suppl 1) A217.
34. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishio K et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001 50 2094-2099.
35. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002 143 998-1007.
36. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Letters 2001 507 142-146.
37. Delporte ML, Funahashi T, Takahashi M, Matsuzawa Y & Brichard SM. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochemical Journal 2002 367 677-685.
38. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y & Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. Journal of Clinical Endocrinology and Metabolism 2002 87 4652-4656.
39. Matsubara M, Maruoka S & Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology 2002 147 173-180.
40. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Sciences 2002 103 137-142.
41. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma concentrations of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis and Thrombosis Vascular Biology 2000 20 1595-1599.
42. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741.
43. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
44. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002 360 57-58.
45. Lihn AS, Ostergard T, Nyholm B, Pedersen SB, Richelsen B & Schmitz O. Adiponectin mRNA expression in subcutaneous adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. American Journal of Physiology. Endocrinology and Metabolism 2003 284 E443-E448.
46. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. PNAS 2000 97 14478-14483.
47. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002 51 37-41.
48. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002 51 536-540.
49. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002 51 2306-2312.
50. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Human and Molecular Genetics 2002 11 2607-2614.
51. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M et al. Association of adiponectin mutation with type 2 diabetes. A candidate gene for the insulin resistance syndrome. Diabetes 2002 51 2325-2328.
52. Matsubara M, Maruoka S & Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. Journal of Clinical Endocrinology and Metabolism 2002 87 2764-2769.
53. Matsuzawa Y, Funahashi T & Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Annals of the New York Academy of Sciences 1999 892 146-154.
54. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Journal of Clinical Endocrinology and Metabolism 2001 86 3815-3819.
55. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M et al. The effect of thiazolidinedione on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002 51 2968-2974.
56. Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y et al. Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002 25 376-380.
57. Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 2002 51 314-317.
58. Yamamoto Y, Hirose H, Miyashita K, Nishikai K, Saito I, Taniyama M et al. PPARgamma2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism 2002 51 1407-1409.
59. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology 2002 13 134-141.
60. Imagawa A, Funahashi T, Nakamura T, Noriwaki M, Tanaka S, Hishizawa H et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002 25 1665-1666.
61. Delporte ML, Lambert MJ, Hermans MP & Brichard SM. Hyperadiponectinemia in anorexia nervosa. Diabetologia 2002 45 (Suppl 1) A223-A224.
62. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2002 290 1084-1089.
63. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA et al. Adiponectin is not altered with exercise training despite enhanced insulin action. American Journal of Physiology. Endocrinology and Metabolism 2002 283 E861-E865.
64. Kappes A & Loffler G. Influences of ionomycin, dibutyrylcycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Hormone and Metabolic Research 2000 32 548-554.
65. Zhang Y, Matheny M, Zolotukhin S, Tumer N & Scarpace JP. Regulation of adiponectin and leptin gene expression in white and brown adipose tissue: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochimica et Biophysica Acta 2002 1584 115-122.
66. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochemical and Biophysical Research Communications 2001 288 1102-1107.
67. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in wholebody insulin sensitivity in humans. Diabetes 2002 51 1884-1888.
68. Kazumi T, Kawaguchi A, Sakai K, Hirano T & Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than that with optimal blood pressure. Diabetes Care 2002 25 971-976.
69. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103 1057-1063.
70. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002 105 2893-2898.
71. Yamauchi T, Oike Y, Kamon J, Waki H, Komeda K, Tsuchida A et al. Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nature Genetics 2002 30 221-226.
72. Haque WA, Shimomura I, Matsuzawa Y & Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. Journal of Clinical Endocrinology and Metabolism 2002 87 2395-2398.